Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for Osteomyelitis (CRO-OSTEO)
Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for the Treatment of Diabetic Foot Osteomyelitis (CRO-OSTEOMYELITIS)
Sponsor: Loyola University
Terminated
The study was stopped for feasibility (i.e., low recruitment)
Other terminated trials from Loyola University
Other Osteomyelitis trials with similar outcome
Listed as NCT02168816, this PHASE2 trial focuses on Osteomyelitis and remains terminated or withdrawn. Sponsored by Loyola University, it has been updated 9 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE2
-
Aug 2018 — Jan 2021 [monthly]
Terminated PHASE2
▶ Show 4 earlier versions
-
Jul 2018 — Aug 2018 [monthly]
Terminated PHASE2
Status: Recruiting → Terminated
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2
First recorded
Mar 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Loyola University
For direct contact, visit the study record on ClinicalTrials.gov .